Trial Profile
Safety of erythrocyte encapsulated asparaginase in patients with relapsed acute lymphoblastic leukaemia.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jul 2014
Price :
$35
*
At a glance
- Drugs ERY-ASP (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 14 Jul 2014 New trial record